Nov 16, 2026

Medtronic Announces First ENT Clinical Cases using Stealth AXiS™ ENT Navigation System in Europe

First ENT cases outside the U.S. mark next step in expanding access to the next-generation navigation platform from Medtronic

Nov. 16, 2026 – Medtronic, a global leader in healthcare technology, today announced the first clinical cases using the Stealth AXiS™ ENT navigation system for ear, nose, and throat (ENT) procedures in Europe. The initial cases, performed at eight hospitals across Austria, Germany, Norway, and the United Kingdom, mark the first uses of the Stealth AXiS™ ENT navigation system for ENT procedures outside the United States, expanding access to Medtronic’s next-generation navigation platform for surgeons and patients across the region.

Built around real-world ENT workflows, the Stealth AXiS™ surgical system is designed to support surgeons navigating basic to complex anatomy of the sinuses and skull base. The system combines advanced visualization, high-precision navigation and connected workflow capabilities to support procedural efficiency and surgical confidence in the operating room.

“Achieving the first ENT procedures with the Stealth AXiS™ ENT navigation system in Europe is an important milestone for the patients and surgeons we serve,” said Sean Haag, President of the Ear, Nose, & Throat business at Medtronic. “After more than 25 years of advancing ENT surgical technologies, we’re focused on what comes next: building a more connected, intelligent approach to ENT care. The Stealth AXiS™ ENT navigation system is an important part of that vision, creating a foundation we can continue to build on with our customers around the world.”

The Stealth AXiS™ ENT navigation system is part of Medtronic’s AiBLE™ ENT smart ecosystem, which connects technologies, data, and workflows across the surgical experience. By bringing navigation together with other technologies across the sinus care portfolio, the ecosystem is designed to help create a more connected approach to care and support surgeons before, during, and beyond the procedure.

“Around the world, we are building the next generation of ENT care together with our surgeons,” said Panos Drakoulas, VP of International for the Medtronic Ear, Nose, & Throat business. “These first European ENT procedures with the Stealth AXiS™ ENT navigation system are a clear example of that ambition becoming reality. Our teams across the region have worked closely with surgeons and hospitals to bring this latest technology into the OR, and we’re proud to partner with them as we continue to advance and shape the future together.”

The first European ENT cases build on the Stealth AXiS™ surgical system’s U.S. launch earlier this year and its June 2026 CE mark for ENT procedures (CE-ENT-2600113). In October 2026, the system was named to TIME’s Best Inventions of 2026 list in the Medical & Healthcare category, recognizing its contribution to advancing surgical technology. The system has also received regulatory clearance for spine and cranial procedures, supporting Medtronic’s broader vision for a connected surgical platform across specialties.

As Medtronic continues to expand the AiBLE™ ENT ecosystem, the company is focused on bringing together technologies and insights that can help surgeons deliver care with greater confidence while creating the foundation for what’s next in ENT surgery.

Additional clinical cases are planned across Europe and other international markets where the system is approved and commercially available in the coming weeks/months as the Stealth AXiS™ surgical system becomes accessible to more ENT surgeons and hospitals.

About the Ear, Nose, & Throat Business at Medtronic
Medtronic’s Ear, Nose, and Throat (ENT) business is the global market leader in ENT, delivering innovative technologies that impact nearly 3 million patients each year. For more than 25 years, we have partnered with physicians to advance care across the specialty. Our portfolio supports surgical procedures related to chronic rhinosinusitis and head and neck cancers, spanning surgical navigation, tissue health, powered instruments, localized drug delivery, intraoperative nerve monitoring, and parathyroid detection.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries.

Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary.

For more information on Medtronic, visit www.Medtronic.com and follow Medtronic on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Product availability, indications, and regulatory status vary by country. Healthcare professionals should refer to the applicable product labeling and instructions for use in their market for indications, warnings, precautions, and operating instructions.

Information contained herein is not medical advice and should not be used as an alternative to speaking with your doctor.

Discuss indications, contraindications, warnings, precautions, adverse events and any further information with your health care professional.

Medtronic products placed on European markets comply with EU and UK legislation (if applicable) on medical devices.

The material on this website should not be considered the exclusive source of information, it does not replace or supersede information contained in the device manual(s).

Please note that the intended use of a product may vary depending on geographical approvals.

See the device manual(s) for detailed information regarding the intended use, the (implant) procedure, indications, contraindications, warnings, precautions, and potential adverse events.

For MRI compatible device(s), consult the MRI information in the device manual(s) before performing a MRI.

If a device is eligible for eIFU usage, instructions for use can be found at Medtronic’s website manuals.medtronic.com.

Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.

For any further information, contact your local Medtronic representative.

Contacts:

Marie Gentile
Public Relations
+1-404-693-6028

Ingrid Goldberg
Investor Relations
+1-763-505-2696